Last edition
News about "Lupin, Granules India recall around 9.71 lakh bott"
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US
Lupin and Granules India are recalling close to 9.71 lakh bottles of generic diabetes drug in the US due to the possibility of the affected lot containing cancer-causing nitrosodimethylamine (NDMA) above the acceptable intake limit
Lupin, Granules India Recall Around 9.71 Lakh Bott | 27/07/2020 | By Darshana | 412
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members